Abstract
Angiogenesis, characterized by the development of new blood vessels from preexisting vasculature, is an important aspect of both healthy and disease states. Recently, reactive oxygen species (ROS) have garnered increased attention as mediators of cell signaling, extending its role beyond simple oxidative stress and damage. Studies have gradually begun to determine links between ROS and cell survival, cell signaling, and the pathophysiology of diseases, both in vitro and in vivo. There are multiple players involved in ROS regulation, with NADPH oxidase, the mitochondria, and superoxide dismutase being some of the most studied regulators. These regulators of ROS have been linked to downstream signaling of a variety of signaling factors, such as vascular endothelial growth factor (VEGF). In addition, ROS have been identified to play a critical role in cells essential for the development of new vasculature, including endothelial, immune, and progenitor cells. Furthermore, a number of studies are pointing at ROS as being an important regulator of pathological angiogenesis in various diseases such as diabetes and tumorigenesis. Herein, we review the literature with regard to ROS regulation of angiogenesis, which has gained more interest in recent years, as we begin to comprehend ROS not as a group of cytotoxic waste products but as critical regulators of angiogenic homeostasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Shabrawey M, Rojas M, Sanders T, Behzadian A, El-Remessy A, Bartoli M, Parpia AK, Liou G, Caldwell RB (2008) Role of NADPH oxidase in retinal vascular inflammation. Invest Ophthalmol Vis Sci 49:3239–3244
Arbiser JL, Petros J, Klafter R, Govindajaran B, Mclaughlin ER, Brown LF, Cohen C, Moses M, Kilroy S, Arnold RS, Lambeth JD (2002) Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci 99(2):715–720
Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221–228
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Shatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967
Bae J, Park D, Lee Y-S, Jeoung D (2008) Interleukin-2 promotes angiogenesis by activation of Akt and increase of ROS. J Microbiol Biotechnol 18:377–382
Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506
Bedard K, Krause K-H (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245–313
Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737–744
Bokoch GM, Diebold BA (2002) Current molecular models for NADPH oxidase regulation by RAC GTPase. Blood 100:2692–2695
Brand MD, Affourtit C, Esteves TC, Green K, Lambert AJ, Miwa S, Pakay JL, Parker N (2004) Serial review: the powerhouse takes control of the cell: the role of mitochondria in signal transduction. Free Radic Biol Med 37:755–767
Brandes RP, Schröder K (2008) Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol 19:513–518
Brown DI, Griendling KK (2009) Nox proteins in signal transduction. Free Radic Biol Med 47:1239–1253
Brown MR, Miller FJ, Li W-G, Ellingson AN, Mozena JD, Chatterjee P, Engelhardt JF, Zwacka RM, Oberley LW, Fang X, Spector AA, NWeintrauc NL (1999) Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ Res 85:524–533
Cahilly C, Ballantyne CM, Lim D-S, Gotto A, Marian AJ (2000) A variant of p22phox, involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86:391–395
Cai H, Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87:840–844
Carmeliet P (2004) Manipulating angiogenesis in medicine. J Intern Med 255(5):538–561
Cerandini DJ, Yao D, Grogan RH, Callaghan MJ, Edelstein D, Brownlee M, Gurtner GC (2008) Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. J Biol Chem 283:10930–10938
Cho M, Hunt TK, Hussain MZ (2001) Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release. Am J Physiol Heart Circ Physiol 280:H2357–H2363
Chua CC, Hamdy RC, Chua BHL (1998) Upregulation of vascular endothelial growth factor by H2O2 in rat heart endothelial cells. Free Radic Biol Med 25(8):891–897
Conner KM, Subbaram S, Regan KJ, Nelson KK, Mazurkiewicz JE, Bartholomew PJ, Alpin AE, Tai Y-T, Aguirre-Ghiso J, Flores SC, Melendez JA (2005) Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 280:16916–16924
Corada M, Zanetta L, Orsenigo F, Breviario F, Lampugnani MG, Bernasconi S, Liao F, Hicklin DJ, Bohlen P, Dejana E (2002) A monoclonal antibody to vascular endothelial – cadherin inhibits tumor angiogenesis without side effects on endothelial permeability. Blood 100:905–911
Craige SM, Chen K, Pei Y, Li C, Huang X, Chen C, Shibata R, Sato K, Walsh K, Keaney JF Jr (2011) NADPH oxidase 4 promotes endothelial angiogenesis though endothelial nitric oxide synthase activation. Circulation 124:731–740
Daghini E, Zhu X-Y, Versari D, Bentley MD, Napoli C, Lerman A, Lerman LO (2007) Antioxidant vitamins induce angiogenesis in the normal pig kidney. Am J Physiol Renal Physiol 293:F371–F381
Dai S, He Y, Zhang H, Yu L, Wan T, Xu Z, Jones D, Chen H, Min W (2009) Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis. Arterioscler Thromb Vasc Biol 29(4):495–502
Davies KJA (1999) The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 48:41–47
Desouki MM, Kulawiec M, Bansal S, Das G, Singh KK (2005) Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther 4(12):1367–1373
Diebold I, Djordjevic T, Petry A, Hatzelmann A, Tenor H, Hess J, Görlach A (2009) Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 an NADPH oxidase 2. Circ Res 104:1169–1177
Dunmore BJ, McCarthy MJ, Naylor R, Brindle NP (2007) Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaque. J Vasc Surg 45:155–159
Ebrahimian TG, Heymes C, You D, Blanc-Brude O, Mees B, Waeckel L, Duriez M, Vilar J, Brandes RP, Levy BI, Shah AM, Silvestre J-S (2006) NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 169(2):719–728
Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev 8:579–591
Faraci FM, Didion SP (2004) Vascular protection: superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24:1367–1373
Ferrara N, Gerber H-P, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669–676
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4–6
Fortuño A, San José G, Moreno MU, Díez J, Zalba G (2005) Oxidative stress and vascular remodelling. Exp Physiol 90:457–462
Frey RS, Ushio-Fukai M, Malik AB (2009) NADPH oxidase-dependent signaling in endothelial cells: role in physiology and pathophysiology. Andioxid Redox Sign 11(4):791–810
Garrido-Urbani S, Jemelin S, Deffert C, Carnesecchi S, Basset O, Szyndralewiez C, Heitz F, Page P, Montet X, Michalik L, Arbiser J, Rüegg C, Krause K-H, Imhof B (2011) Targeting vascular NADPH oxidase 1 blocks tumor angiogenesis through a PPARα mediated mechanism. PLoS One 6:e14665
Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouysségur J, Yaniv M, Mechta-Grigoriou F (2004) JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118:781–794
Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161:1163–1177
Groleau J, Dussault S, Haddad P, Turgeon J, Ménard C, Chan JS, Rivard A (2010) Essential role of copper-zinc superoxide dismutase for ischemia-induced neovascularization via modulation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 30:2173–2181
Grzenkowicz-Wydra J, Cisowski J, Nakonieczna J, Zarębski A, Udilova N, Nohl H, Józkowicz A, Podhajska A, Dulak J (2004) Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor. Mol Cell Biochem 264:169–181
Haddad P, Dussault S, Groleau J, Turgeon J, Michaud S-E, Ménard C, Perez G, Maingrette F, Rivard A (2009) Nox2-containing NADPH oxidase deficiency confers protection from hindlimb ischemia in conditions of increased oxidative stress. Arterioscler Thromb Vasc Biol 29:1522–1528
Haddad P, Dussault S, Groleau J, Turgeon J, Maingrette F, Rivard A (2011) Nox2-derived reactive oxygen species contribute to hypercholesterolemia-induced inhibition of neovascularization: effects on endothelial progenitor cells and mature endothelial cells. Atherosclerosis 217(2):340–349
Hamilton CA, Miller WH, Al-Benna S, Brosnan MJ, Drummond RD, McBride MW, Dominiczak AF (2004) Strategies to reduce oxidative stress in cardiovascular disease. Clin Sci 106:219–234
Harfouche R, Abdel-Malak NA, Brandes RP, Karson A, Irani K, Hussain SNA (2005) Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor signaling. FASEB J 19(12):1728–1730
Hellström M, Kalén M, Lindahl P, Abramsson A, Betsholtz C (1999) Role of PDGF-B and PDGFR-β in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126:3047–3055
Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D’Amore PA (1999) Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ Res 84:298–305
Hirst J, King MS, Pryde KR (2008) The production of reactive oxygen species by complex I. Biochem Soc Trans 36:976–980
Ikeda S, Yamaoka-Tojo M, Hilenski L, Patrushev N, Anwar GM, Quinn MT, Ushio-Fukai M (2005) IQGAP1 regulates reactive oxygen species-dependent endothelial cell migration through interacting with Nox2. Arterioscler Thromb Vasc Biol 25:2295–2300
Inoue N, Takeshita S, Gao D, Ishida T, Kawashima S, Akita H, Tawa R, Sakurai H, Yokoyama M (2001) Lysophosphatidylcholine increases the secretion of matrix metalloproteinase 2 through the activation of NADP/NADPH oxidase in cultured aortic endothelial cells. Atherosclerosis 155:45–52
Izuta H, Chikaraishi Y, Adachi T, Shimazawa M, Sugiyama T, Ikeda T, Hara H (2009) Extracellular SOD and VEGF are increased in vitreous bodies from proliferative diabetic retinopathy patients. Mol Vis 15:2663–2672
Jay D, Hitomi H, Griendling KK (2006) Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 40:183–192
Jenkinson L, Bardhan KD, Atherton J, Kalia N (2002) Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: role of cytokines. Dig Dis Sci 47(8):1857–1862
Kang D-H, Anderson S, Kim Y-G, Mazzalli M, Suga S-I, Jefferson A, Gordon KL, Oyama TT, Hughes J, Hugo C, Kerjaschki D, Schreiner GF, Johnson RJ (2001) Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis 37(3):601–611
Kangas-Kontio T, Vavuli S, Kakko SJ, Penna J, Savolainen E-R, Savolainen MJ, Liinamaa MJ (2009) Polymorphism of the manganese superoxide dismutase gene but not of vascular endothelial growth factor gene is a risk factor for diabetic retinopathy. Br J Ophthalmol 93:1401–1406
Khatri JJ, Johnson C, Magid R, Lessner SM, Laude K, Dikalov SI, Harrison DG, Sung H-J, Rong Y, Galis ZS (2004) Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109:520–525
Khromova NV, Kopnin PB, Stepanova EV, Agapova LS, Kopnin BP (2009) p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway. Cancer Lett 276:143–151
Kim HW, Lin A, Guldberg RE, Ushio-Fukai M, Fukai T (2007) Essential role of extracellular SOD in reparative neovascularization induced by hindlimb ischemia. Circ Res 101:409–419
Komatsu D, Kato M, Nakayama J, Miyagawa S, Kamata T (2008) NADPH oxidase 1 plays a critical mediating role in oncogenic Ras-induced vascular endothelial growth factor expression. Oncogene 27:4724–4732
Krupinski J, Kaluza J, Kumar P, Kumar S, Wang JM (1994) Role of angiogenesis in patients with cerebral ischemia stroke. Stroke 25:1794–1798
Kubo M, Li T-S, Suzuki R, Ohshima M, Qin S-L, Hamano K (2007) Short-term pretreatment with low-dose hydrogen peroxide enhances the efficacy of bone marrow cells for therapeutic angiogenesis. Am J Physiol Heart Circ Physiol 292:H2582–H2588
Lee S, Jilani SM, KNikolova GV, Carpizo D, Iruela-Arispe ML (2005) Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 169(4):681–691
Lee WL, Harrison RE, Grinstein S (2003) Phagocytosis by neutrophil. Microbes Infect 5:1299–1306
Li L, Renier G (2006) Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression. Metabolism 55:1516–1523
Li J, Wang JJ, Yu Q, Chen K, Mahadev K, Zhang SX (2010a) Inhibition of reactive oxygen species by lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db/db mice. Diabetes 59:1528–1538
Li S-M, Zeng L-W, Feng L, Chen D-B (2010b) Rac-1 dependent intracellular superoxide formation mediates vascular endothelial growth factor-induced placental angiogenesis in vitro. Endocrinology 151:5315–5325
Lin M-T, Yen M-L, Lin C-Y, Kuo M-L (2003) Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Mol Pharmacol 64:1029–1036
Lim SD, Sun C, Lambeth JD, Marshall F, Amin M, Chung L, Petros JA, Arnold RS (2005) Increased Nox1 and hydrogen peroxide in prostate cancer. Prostate 62:200–207
Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP (1998) Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 101:1219–1224
Madamanchi NR, Vendrov A, Runge MS (2005) Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25:29–38
Maehata Y, Ozawa S, Kobayashi K, Kato Y, Yoshino F, Miyamoto C, Izukuri K, Kubota E, Hata R-I, Lee M-C-I (2010) Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells. Free Radic Res 44(8):913–924
Marikovsky M, Nevo N, Vadai E, Harris-Cerruti C (2002) Cu/Zn superoxide dismutase plays a role in angiogenesis. Int J Cancer 97:34–41
Marrotte EJ, Chen D-D, Hakim JS, Chen AF (2010) Manganese superoxide dismutase expression in endothelial progenitor cells accelerates wound healing in diabetic mice. J Clin Invest 120:4207–4219
Martinez P, Esbrit P, Rodrigo A, Alvarez-Arroyo MV, Martinez ME (2002) Age-related changes in parathyroid hormone-related protein and vascular endothelial growth factor in human osteoblastic cells. Osteoporos Int 13:874–881
Monte M, Davel LE, Sacerdote de Lustig E (1997) Hydrogen peroxide is involved in lymphocyte activation mechanisms to induce angiogenesis. Eur J Cancer 33:676–682
Mott JD, Werb Z (2004) Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16:558–564
Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1–13
Nwariaku FE, Lui Z, Zhu X, Nahari D, Ingle C, Wu RF, Gu Y, Sarosi G, Terada LS (2004) NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood 104:3214–3220
Ohshima M, Li T-S, Kubo M, Qin S-L, Hamano K (2009) Antioxidant therapy attenuates diabetes-related impairment of bone marrow stem cells. Circ J 73:162–166
Orlidge A, D’Amore PA (1987) Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J Cell Biol 105:1455–1462
Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, McKinney R, Poole LB, Fukai T, Ushio-Fukai M (2010) Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One 5(4):e10189
Papaharalambus CA, Griendling KK (2007) Basic mechanisms of oxidative stress and reactive oxygen species in cardiovascular injury. Trends Cardiovasc Med 17:48–54
Park JE, Barbul A (2004) Understanding the role of immune regulation in would healing. Am J Surg 187(Suppl):11S–16S
Pathi SS, Jutooru I, Chadalapaka G, Sreevalsan S, Anand S, Thatcher GRJ, Safe S (2011) GT-094, a NO-NSAID, inhibits colon cancer cell growth by activation of a reactive oxygen species-microRNA-27A: ZBTB10-specificity protein pathway. Mol Cancer Res 9:195–205
Pearson JD (2009) Endothelial progenitor cells – hype or hope? J Thromb Haemost 7:255–262
Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, Walter P, Yaffe M (1995) Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1271:67–74
Rivard A, Silver M, Chen D, Kearney M, Magner M, Annex B, Peters K, Isner JM (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am J Pathol 154(2):355–363
Rivera J, Sobey CG, Walduck AK, Drummond GR (2010) Nox isoforms in vascular pathophysiology: insights from transgenic and knockout mouse models. Redox Rep 15(2):50–63
Ross R (1999) Atherosclerosis – an inflammatory disease. New Eng J Med 340:115–126
Ruiz-Ginés JA, López-Ongil S, González-Rubio M, González-Santiago L, Rodríguez-Puyol M, Rodríguez-Puyol D (2000) Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharmacol 35(1):109–113
Sato Y, Rifkin DB (1989) Inhibition of endothelial cell movement by pericytes and smooth muscle ceils: activation of a latent transforming growth factor-B l-like molecule by plasmin during co-culture. J Cell Biol 109:309–315
Scarpino S, Marchitti S, Stanzione R, Evangelista A, Di Castro S, Savoia C, Quarta G, Sciarretta S, Ruco L, Volpe M, Rubattu S (2009) Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro. J Hypertens 27:1804–1813
Schleicher M, Shepard BR, Suarez Y, Fernandez-Hernando C, Yu J, Pan Y, Acevedo LM, Shadel GS, Sessa WC (2008) Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol 180(1):101–112
Simon AM, McWhorter AR (2002) Vascular abnormalities in mice lacking the endothelial gap junction proteins connexin37 and connexin40. Dev Biol 251:206–220
Simons M (2005) Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed. J Am Coll Cardiol 46:835–837
Singh U, Jialal I (2006) Oxidative stress and atherosclerosis. Pathophysiology 13:129–142
Stefano RD, Felice F, Balbarini A (2009) Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 15:1095–1106
Strålin P, Karlsson K, Johansson BO, Marklund SL (1995) The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 15:2032–2036
Sun D, McCrae KR (2006) Endothelial-cell apoptosis induced by cleaved high-molecular-weight kininogen (HKa) is matrix dependent and requires the generation of reactive oxygen species. Blood 107:4714–4720
Tchaikovski V, Olieslagers S, Böhmer F-D, Waltenberger J (2009) Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes. Circulation 120:150–159
Thannickal VJ, Fanburg BL (2000) Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279:L1005–L1028
Tojo T, Ushio-Fukai M, Yamaoka-Tojo M, Ikeda S, Patrushev N, Alexander RW (2005) Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111:2347–2355
Urao N, Inomata H, Razvi M, Kim HW, Wary K, McKinney R, Fukai T, Ushio-Fukai M (2008) Role of Nox2-based NADPH oxidase in bone marrow and progenitor cell function involved in neovascularization induced by hindlimb ischemia. Circ Res 103:212–220
Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW (2002) Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91:1160–1167
van Hinsbergh VWM, Koolwijk P (2008) Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res 78:203–212
Waeckel L, Mallat Z, Potteaux S, Combadière C, Clergue M, Duriez M, Bau L, Gerard C, Rollins BJ, Tedgui A, Levy BI, Silvestre J-S (2005) Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. Circ Res 96:576–582
Waltenberger J (2009) VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus. Biochem Soc Trans 37:1167–1170
Walter A, Etienne-Selloum N, Brasse D, Schleiffer R, Bekaert V, Vanhoutte PM, Beretz A, Schini-Kerth VB (2009) Red wine polyphenols prevent acceleration of neovascularization by angiotensin II in the ischemic rat hindlimb. J Pharmacol Exp Ther 329(2):699–707
Wetering SV, van Buul JD, Quik S, Mul FPJ, Anthony EC, ten Klooster J-P, Collard JG, Hordijk PL (2002) Reactive oxygen species mediate Rac-induced loss of cell-cell adhesion in primary human endothelial cells. J Cell Sci 115:1837–1846
Wu RF, Xu YC, Ma Z, Nwariaku FE, Sarosi GA Jr, Terada LS (2005) Subcellular targeting of oxidants during endothelial cell migration. J Cell Biol 171:893–904
Xia C, Meng Q, Liu L-Z, Rojanasakul Y, Wang X-R, Jiang B-H (2007) Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Res 67:10823–10830
Yasuda M, Shimizu S, Ohhinata K, Naito S, Tokuyama S, Mori Y, Kiuchi Y, Yamamoto T (2002) Differential roles of ICAM-1 and E-selectin in polymorphonuclear leukocyte-induced angiogenesis. Am J Physiol Cell Physiol 282:C917–C925
Yasuda M, Shimizu S, Tokuyama S, Watanabe T, Kiuchi Y, Yamamoto T (2000) A novel effect of polymorphonuclear leukocytes in the facilitation of angiogenesis. Life Sci 66(21):2113–2121
Yoder MC, Ingram DA (2009) Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system. Curr Opin Hematol 16:269–273
Zhu X-Y, Rodriguez-Porcel M, Bentley MD, Chade AR, Sica V, Napoli C, Caplice N, Ritman EL, Lerman A, Lerman LO (2004) Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109:2109–2115
Zhuang J, Jiang T, Lu D, Luo Y, Zheng C, Feng J, Yang D, Chen C, Yan X (2010) NADPH oxidase 4 mediates reactive oxygen species induction of CD146 dimerization in VEGF signal transduction. Free Radic Biol Med 49:227–236
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Trane, A.E., Bernatchez, P.N. (2014). Therapeutic Insight Into Reactive Oxygen Species Regulation of Neovascularization. In: Laher, I. (eds) Systems Biology of Free Radicals and Antioxidants. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30018-9_60
Download citation
DOI: https://doi.org/10.1007/978-3-642-30018-9_60
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30017-2
Online ISBN: 978-3-642-30018-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences